chr1-51840414-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001101662.2(NRDC):c.442G>A(p.Glu148Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00015 in 1,595,472 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001101662.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRDC | NM_001101662.2 | c.442G>A | p.Glu148Lys | missense_variant | 2/31 | ENST00000352171.12 | NP_001095132.1 | |
NRDC | NM_002525.3 | c.442G>A | p.Glu148Lys | missense_variant | 2/33 | NP_002516.2 | ||
NRDC | NM_001242361.2 | c.46G>A | p.Glu16Lys | missense_variant | 2/33 | NP_001229290.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NRDC | ENST00000352171.12 | c.442G>A | p.Glu148Lys | missense_variant | 2/31 | 1 | NM_001101662.2 | ENSP00000262679 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000920 AC: 14AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000322 AC: 80AN: 248400Hom.: 0 AF XY: 0.000297 AC XY: 40AN XY: 134484
GnomAD4 exome AF: 0.000156 AC: 225AN: 1443324Hom.: 0 Cov.: 28 AF XY: 0.000170 AC XY: 122AN XY: 719402
GnomAD4 genome AF: 0.0000920 AC: 14AN: 152148Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 26, 2021 | The c.442G>A (p.E148K) alteration is located in exon 2 (coding exon 2) of the NRDC gene. This alteration results from a G to A substitution at nucleotide position 442, causing the glutamic acid (E) at amino acid position 148 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at